WeiFuChun
- Generic Name
- WeiFuChun
Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia
Phase 4
Not yet recruiting
- Conditions
- Gastric Intestinal Metaplasia
- Interventions
- First Posted Date
- 2024-09-24
- Last Posted Date
- 2024-09-24
- Lead Sponsor
- Yongquan Shi
- Target Recruit Count
- 400
- Registration Number
- NCT06610266
Clinical Study of Weifuchun Treatment on Gastric Cancer
- First Posted Date
- 2023-06-05
- Last Posted Date
- 2023-07-25
- Lead Sponsor
- ShuGuang Hospital
- Target Recruit Count
- 72
- Registration Number
- NCT05888675
Clinical Study of Weifuchun Treatment on Precancerous Lesions of Gastric Cancer
Early Phase 1
- Conditions
- Chronic Atrophic Gastritis With Hyperplasia (Diagnosis)
- Interventions
- First Posted Date
- 2019-01-24
- Last Posted Date
- 2019-01-24
- Lead Sponsor
- ShuGuang Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT03814629
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath